Hypercalciuria
11
1
2
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
18.2%
2 terminated out of 11 trials
75.0%
-11.5% vs benchmark
18%
2 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
The Impact of Phosphate Metabolism on Healthy Aging
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
Stone Disease in Children and Their Families
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
Safety and Efficacy of Chlorthalidone in Type 1 Diabetes
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass
Preterm Infants and Nephrocalcinosis
Low Salt Diet in Idiopathic Hypercalciuria
Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria